Biliary Stents Market

Biliary Stents Market Outlook (2022-2027)

The global market for biliary stents is anticipated to progress at a CAGR of 5% and increase from a market valuation of US$ 315.4 million in 2022 to US$ 402.5 million by the end of 2027.

The hospitals segment is expected to expand faster at a CAGR of 6%; this can be attributed to high patient intake capability and the presence of advanced & latest technologies in these settings.

Report Attributes	Details
Biliary Stents Market Size (2022E)	US$ 315.4 Million
Forecasted Market Value (2027F)	US$ 402.5 Million
Global Market Growth Rate (2022-2027)	5% CAGR
China Market Growth Rate (2022-2027)	8% CAGR
Share in Stents Market (2022)	2.3%
Key Companies Profiled	Boston Medical Products B. Braun Melsungen AG Cook Medical Inc. Olympus Corporation CONMED Corporation M.I. Tech Becton, Dickinson and Company ENDO-FLEX GmbH Cardinal Health Merit Medical Systems, Inc. Medtronic plc Cook Medical Inc

Global Sales Analysis of Biliary Stents (2017-2021) Vs. Market Forecasts (2022-2027)

A long, tube-like structure, called a bile duct, helps bile fluid drain from the body. Biliary stents sometimes referred to as bile duct stents are used to treat conditions that block the bile duct. The materials used to create the bile duct stents might be either plastic or metal, which are also called plastic biliary stents or biliary metal stents.

Biliary stents are put into the lumen or duct to maintain the opening and allow for the best possible outflow of the bile. Cholestasis biliary stenting is also helpful in treating bile disorders.

Food digestion depends heavily on bile fluids, which are produced by the liver into the intestinal channel through a bile duct that opens in the intestine. Thus, ignorance of food digestion-related problems can also result in several gastric disorders.

Rising prevalence of gallstones and pancreatic & bile duct cancer are driving up demand for biliary stents. Also, the worldwide biliary stent market is anticipated to flourish due to the increasing use of endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC), both of which offer precise results in the detection of issues with bile and pancreatic channels. PTC biliary stents are used to divert bile away from the bile leakage area.

The market is also expected to increase as a result of the rapidly increasing number of minimally-invasive surgeries and the use of robotics, which enable physicians to carry out a variety of difficult procedures with accuracy and adaptability. Furthermore, compared to conventional surgery, robotic-associated bile duct surgical procedure offers advantages such as shorter hospital stays, lower infection risks, and speedier recovery.

Global sales of biliary stents are expected to increase at a CAGR of 5% and reach US$ 402.5 million by 2027, says Fact.MR, a market research and competitive intelligence provider.

What is Augmenting Worldwide Sales of Biliary Stents?

“High Prevalence of Gastrointestinal Disorders Needing Treatment”

The number of choices for treating pancreatic and biliary illnesses has risen as a result of improvements in gastrointestinal surgery during the past few decades. Compared to conventional open surgical procedures, gastrointestinal therapies have lesser risks.

Before the emergence of stents, surgery was the main treatment for biliary blockage. The mainstay of pancreas divisum therapy is done with the use of pancreatic and biliary stents, as well as emerging technologies such as biodegradable biliary stents and bioabsorbable stents, which have expanded the possibilities for the open surgical treatment of complicated lesions.

Number of pancreatic and biliary procedures is predicted to rise due to the ongoing production of new technologies and intervention techniques for the treatment of pancreatic illnesses. These elements are encouraging more hospitals to launch tenders for the purchase of higher-quality pancreatic and biliary stents.

The market for biliary stents is thus anticipated to rise throughout the projected period as a result of rising awareness of stent-based treatments.

“Endoscopic Biliary Stenting Effective Treatment Method for Pancreatic & Biliary Cancer”

Biliary stent demand has increased as a result of an increase in biliary cancer cases. Hepatic obstruction, gallstones, and other pancreatic and biliary diseases can all be effectively treated by endoscopic biliary stenting.

The market has been stimulated by an increase in ERCP and PTC operations, particularly those that need continuous stenting. Biliary obstruction from malignant cancer is fairly prevalent, as 70% of patients infected with pancreatic cancer present with obstruction.

• According to an article titled 'Pancreatic Duct Variations and the Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis' that was published in the Cureus Journal of Medical Science in 2020, the number of diagnostic and surgical ERCP procedures performed in the United States alone each year ranges from 350,000 to 500,000.

What Can Slow Down Sales of Biliary Stents?

“Complications in Biliary Disorder Treatment Spreads Negative Information”

When used to treat biliary problems, biliary stents can occasionally result in several issues and even cause blockages. These stents have the potential to obstruct blood flow or have unfavourable side effects such as fever, belly ache, hurting muscles, and other symptoms. Also, there is a chance of developing a hole in the duodenum after or during the stent-in-duct procedure, which could result in bleeding and infection.

Pain, vomiting, fever, bleeding, nausea, and acute cholangitis linked to CBD stones are some of the possible side effects of using a biliary metal stent placement/ERCP treatment.

Furthermore, stent misplacement or displacement, obstruction, perforation, collapse, stent fracture, and specific infections are some of the serious problems connected to biliary stents. Throughout the forecast period, these issues are projected to reduce demand for biliary stents.

Why are Key Suppliers of Biliary Stents Focusing on North America?

“High Knowledge & Availability of Advanced Biliary Treatment Technologies”

Due to the region's developed healthcare infrastructure and increased prevalence of chronic diseases, North America is anticipated to boost its market share in the coming years. The elderly population who is prone to diseases such as gallstones, pancreatic cancer, and other malignant obstructions is increasing, and this is one of the main reasons that will influence the growth of the regional market.

Forecasts for the North America biliary stents business will also benefit from rising knowledge of cutting-edge technologies for the diagnosis and treatment of biliary disorders.

Affluent growth is predicted for the Asia Pacific market as a result of the region's ageing population, rising healthcare awareness, government programs to treat bile duct disorders, and increased research and development efforts for pancreatic and bile duct infections. Healthy arterial stents market growth is anticipated in the Middle East and Africa region as a result of developing medical tourism and increased healthcare awareness.

Country-wise Analysis

What Expanding the Market Size of Biliary Stents in the United States?

“High Prevalence of Pancreatic Cancer & Biliary Disorders”

Over the forecast period, it is predicted that the U.S. biliary stents market would increase gradually. This is explained by the fact that biliary illness is becoming more common in the United States.

Acalculous cholecystitis, cholangiocarcinoma, choledocholithiasis, benign biliary strictures, biliary tract disease, gallbladder disease, and other illnesses are examples of biliary diseases. The prevalence of this condition has significantly increased.

• According to projections from the National Pancreas Foundation (2019), there are 50 cases of chronic pancreatitis for every 100,000 people.

Furthermore, awareness regarding different biliary illnesses and treatment drives the market growth. The market for biliary stents is expanding as a result of the rising number of pancreatic cancer patients in the U.S.

• The American Cancer Society reports that there were 57,600 new cases of pancreatic cancer in the country in 2020, up from 55,440 in 2018.

Furthermore, it is projected that the leading players in the U.S. biliary stents market will benefit greatly from the development of cutting-edge digital technologies and smartphone applications for biliary stent management.

What is Fuelling Market Growth in China?

“Rising Cases of Primary Biliary Cholangitis Due to High Adoption of Western Lifestyle & Poor Digestive System”

The first primary biliary cholangitis case in China was documented in 1958. However, a thorough outline of the traits of Chinese primary biliary cholangitis patients wasn't published until 1990.

• The number of Chinese patients with primary biliary cholangitis (PBC) is increasing steadily annually, according to the National Center for Biotechnology Information.

The broadening of the understanding of the disease, the use of convenient autoantibody detection kits, and changes in the spectrum of liver disease may all be contributing factors to this rise. However, it can also be a result of China's environmental features becoming more westernized.

Primary biliary cholangitis is currently the subject of large and important academic and clinical research in China, with significant advancements in the fields of diagnostic methods, therapeutic approaches, and fundamental biology.

Thus, the improper diet and poor digestion system can also result in biliary problems, giving rise to biliary stent sales. Sales of biliary stents in China are expected to increase at a CAGR of 8% from 2022 to 2027 and reach US$ 83 million by 2027.

Category-wise Analysis

Why is Demand for Biliary Metal Stents Higher?

“Effective Medical End Results & Lower Risk of Tumour Formation”

Metal stents are mesh-like tubes made of fine wire that are put into a human body lumen or duct to keep the pancreatic or bile duct open. The post-expansion diameter of self-expandable metal stents ranges from 6 to 10 millimetres.

Different pancreatic and biliary-related disorders, including digestive and biliary leaks, pancreatic cancer, and other malignant obstructions causing blockage of digestive and biliary channels, are treated using a variety of metal stents. The usage of metal stents covered with polymer covering is growing as a result of the lower risk of problems since they don't allow tumours to grow inside the stent.

Compared to plastic stents, expandable stents with a cover minimize biliary leakage. Also, self-expandable metal stents may be more effective than plastic stents at preventing other common adverse events such as bleeding, stent blockage, and dislocation due to their compression and expansion effects. Metal biliary stents are preferred over plastic biliary stents for the reasons mentioned above, making them a dominant market segment.

Competitive Landscape

The global market for biliary stents is fragmented and moderately competitive. Some of the top players hold a major market share. Numerous regional competitors are anticipated to participate in the global biliary stents market throughout the forecast period due to the increasing prevalence of stomach-related diseases and rising patient awareness levels.

Major competitors in the market for biliary stents have entered into partnerships as a result of the intensifying competition and ongoing technical improvements.

Recent Developments and Innovations in Biliary Stents Market

• Boston Scientific Corporation declared in October 2021 that its Advanix biliary plastic stents now have both the CE Mark and 510(k) clearance from the U.S. Food and Drug Administration. The clearance will expand the company's product line, increasing the company's revenue.
• Olympus Corporation introduced its self-expanding metal stent, the HANAROSTENT, in July 2020. FDA 510(k) clearance has been granted for the Hanarostent biliary stent.

Some Top Biliary Stent Product Details

• The self-expanding Zilver 635® biliary stent is used to relieve the symptoms of malignant tumours.
• Cotton-Leung® biliary stent sets are used to empty clogged biliary channels.
• A fully covered metal stent designed to relieve the symptoms of malignant strictures in the biliary tree is called the GORE® VIABIL® Short Wire Biliary Endoprosthesis. The unique anti-migration technology used in gore viabil stents helps lower the risk of repeat interventions.
• The tannenbaum stent is a novel plastic biliary stent with no side holes. The tannenbaum stent delivers efficient palliative biliary decompression in all patients.

Key Segments in Biliary Stents Industry Research

• By Type :

  • Metal
  • Plastic

• By Application :

  • Bilio-pancreatic Leakages
  • Pancreatic Cancer
  • Benign Biliary Structures
  • Gallstones
  • Others

• By End User :

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • MEA